Your Passport to the Newsiverse
As long-haul infections continue to surge, and climate change pushes ticks into new habitats, finding out the causes of these conditions and coming up with cures will become ever more essential.
As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.
A sharp surge in the number of diabetes patients, 77 million and counting, has turned India into a hotspot for deals to buy or sell prestigious medicine brands to treat the chronic disease. In the latest move, the USD60 billion drug giant Merck, known as MSD in India, has decided to put its iconic anti-diabetes […]
Image credit: Compiled by Manali Ghosh via AI Synopsis Advent controlled-BSV has charted an exceptional turnaround over the last five years, seeing a 3x jump in its valuation. Its specialised products in women’s health and a robust research pipeline makes it a cynosure of all eyes. As the bidding race to buy BSV intensifies, ET […]